Entries by aaron

How many leaves allowed for PG medical students? NMC specifies in PGMER FAQs

New Delhi: The National Medical Commission (NMC) has recently specified how many leaves a medico can take while pursuing PG medical courses. According to a recent NMC notification, PG medical students are allowed “weekly one-day off (subject to exigencies of work). In addition, they are eligible for twenty days of Paid Casual Leave. Five days of […]

37 km in 16 minutes: Mid-surgery tissue sample transported via drone for pathological testing

New Delhi: The Indian Council of Medical Research (ICMR) on Wednesday announced the successful transportation of a tissue sample via drone from a peripheral hospital to a tertiary setting for advanced pathological testing. This innovative approach aims to expedite the determination of whether the resected tissue is cancerous, potentially revolutionizing surgical decision-making. According to ICMR, […]

Respiratory syncytial virus has increased frequency of transplacental transmission in Pregnant Women: Study

A recent comprehensive study illuminated the transmission of respiratory viral infections from pregnant women to their offspring. This research uncovered significant disparities between the respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The key findings were published in the recent issue of American Journal of Respiratory and Critical Care Medicine. This prospective […]

Trigonelline supplementation has therapeutic potential for age-associated muscle decline in sarcopenia: Study

Switzerland: A research team, including researchers from Nestle Research, revealed that a compound found in fenugreek and coffee, but also made in the gut microbiome, can improve muscle function in aging mice, humans, and worms. “Dietary trigonelline supplementation in male mice prevents fatigue and enhances strength during aging,” the researchers reported in Nature Metabolism. “We […]

Triple conventional synthetic DMARD therapy may lower disease activity in RA patients: Study

A recent study published in the Joint Bone Spine journal unveiled comparative insights into the effectiveness of conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) treatment strategies for rheumatoid arthritis (RA), focusing on patient retention rates between two popular treatment combinations. This study provides important data on the real-world application of triple therapy (methotrexate, sulfasalazine and hydroxychloroquine) […]

Study compares patch test positivity: 24 versus 48 hours of occlusion time in allergic contact dermatitis patients

India: A recent prospective study published in Contact Dermatitis compared patch test positivity after 24 and 48 hours of occlusion time in patients with allergic contact dermatitis (ACD).  The researchers reported no significant difference in patch test among ISS allergens after either occlusion time, 48 h occlusion performed significantly better versus 24 h when reactions of all allergens […]

Transarterial chemoembolization and sorafenib combo improves survival in hepatocellular patients with PVTT: JAMA

China: A recent study showed a longer recurrence-free survival and overall survival with the combination of sorafenib and transarterial chemoembolization as postoperative adjuvant therapy among patients with hepatocellular carcinoma with portal vein tumor thrombus (PVTT). “The randomized clinical trial comprising 158 patients showed that both the median recurrence-free survival and median overall survival were significantly […]

Urine test halves painful procedures in bladder cancer follow up, new trial shows

A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe through the urethra into the bladder, which allows a clinician to look at the bladder lining for signs of cancer. While they are predominantly safe […]

Brepocitinib Demonstrates Promising Phase 2 Results in Uveitis Treatment

Priovant Therapeutics recently unveiled promising results from the NEPTUNE Phase 2 study by testing the efficacy of brepocitinib in patients with non-anterior non-infectious uveitis (NIU) which can lead to severe visual impairment. This study highlights the potential of brepocitinib to revolutionize treatment paradigms in autoimmunity by specifically targeting a condition with few effective treatments currently […]